$KITE Kite Pharma, Inc. Insider Trading Week 51/2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Kite Pharma, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Kite Pharma, Inc. in week 51/2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 21 2015 | KITE | Kite Pharma, Inc. | Tomasello Shawn | Chief Commercial Of ... | Option Exercise | A | 63.87 | 160,000 | 10,219,200 | 160,000 | |
| Dec 21 2015 | KITE | Kite Pharma, Inc. | Tomasello Shawn | Chief Commercial Of ... | Grant | A | 0.00 | 44,000 | 0 | 54,000 | 10 K to 54 K (+440.00 %) |
| Dec 21 2015 | KITE | Kite Pharma, Inc. | Better Marc | VP, Product Science ... | Option Exercise | A | 63.87 | 8,800 | 562,056 | 8,800 | |
| Dec 21 2015 | KITE | Kite Pharma, Inc. | Better Marc | VP, Product Science ... | Grant | A | 0.00 | 5,800 | 0 | 7,688 | 1.9 K to 7.7 K (+307.20 %) |
| Dec 21 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Option Exercise | A | 63.87 | 8,800 | 562,056 | 8,800 | |
| Dec 21 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Grant | A | 0.00 | 5,800 | 0 | 8,741 | 2.9 K to 8.7 K (+197.21 %) |
| Dec 21 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Option Exercise | A | 63.87 | 24,800 | 1,583,976 | 24,800 | |
| Dec 21 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Grant | A | 0.00 | 6,900 | 0 | 9,098 | 2.2 K to 9.1 K (+313.92 %) |
| Dec 21 2015 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | SVP Clinical Develo ... | Option Exercise | A | 63.87 | 26,400 | 1,686,168 | 26,400 | |
| Dec 21 2015 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | SVP Clinical Develo ... | Grant | A | 0.00 | 7,400 | 0 | 13,742 | 6.3 K to 13.7 K (+116.68 %) |
| Dec 21 2015 | KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Devel ... | Option Exercise | A | 63.87 | 33,000 | 2,107,710 | 33,000 | |
| Dec 21 2015 | KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Devel ... | Grant | A | 0.00 | 9,200 | 0 | 9,200 | 0 to 9.2 K |
| Dec 21 2015 | KITE | Kite Pharma, Inc. | Chang David D | EVP, R&D, Chief Med ... | Option Exercise | A | 63.87 | 66,100 | 4,221,807 | 66,100 | |
| Dec 21 2015 | KITE | Kite Pharma, Inc. | Chang David D | EVP, R&D, Chief Med ... | Grant | A | 0.00 | 18,500 | 0 | 25,404 | 6.9 K to 25.4 K (+267.96 %) |
| Dec 21 2015 | KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | COO and CFO | Option Exercise | A | 63.87 | 66,100 | 4,221,807 | 66,100 | |
| Dec 21 2015 | KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | COO and CFO | Grant | A | 0.00 | 18,500 | 0 | 94,007 | 75.5 K to 94 K (+24.50 %) |
| Dec 21 2015 | KITE | Kite Pharma, Inc. | Belldegrun Arie | Chairman, President ... | Option Exercise | A | 63.87 | 100,700 | 6,431,709 | 100,700 | |
| Dec 21 2015 | KITE | Kite Pharma, Inc. | Belldegrun Arie | Chairman, President ... | Grant | A | 0.00 | 28,200 | 0 | 28,200 | 0 to 28.2 K |